home / stock / hbio / hbio quote
Last: | $3.69 |
---|---|
Change Percent: | -0.81% |
Open: | $3.71 |
Close: | $3.72 |
High: | $3.75 |
Low: | $3.66 |
Volume: | 37,725 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.69 | $3.71 | $3.72 | $3.75 | $3.66 | 37,725 | 04-24-2024 |
$3.72 | $3.75 | $3.72 | $3.84 | $3.6309 | 92,086 | 04-23-2024 |
$3.7 | $3.71 | $3.7 | $3.79 | $3.6 | 90,516 | 04-22-2024 |
$3.7 | $3.95 | $3.7 | $4.02 | $3.69 | 87,259 | 04-19-2024 |
$3.97 | $4.1 | $3.97 | $4.31 | $3.86 | 126,604 | 04-18-2024 |
$4.09 | $4.19 | $4.09 | $4.4 | $4.09 | 86,073 | 04-17-2024 |
$4.18 | $4.41 | $4.18 | $4.42 | $4.15 | 66,030 | 04-16-2024 |
$4.44 | $4.21 | $4.44 | $4.45 | $4.15 | 192,772 | 04-15-2024 |
$4.24 | $4.35 | $4.24 | $4.4 | $4.19 | 92,929 | 04-12-2024 |
$4.345 | $4.26 | $4.345 | $4.37 | $4.12 | 55,972 | 04-11-2024 |
$4.26 | $4.48 | $4.26 | $4.62 | $4.16 | 115,527 | 04-10-2024 |
$4.63 | $4.38 | $4.63 | $4.65 | $4.33 | 98,402 | 04-09-2024 |
$4.31 | $4.52 | $4.31 | $4.66 | $4.23 | 185,397 | 04-08-2024 |
$4.52 | $4.43 | $4.52 | $4.58 | $4.3769 | 34,498 | 04-05-2024 |
$4.47 | $4.3 | $4.47 | $4.7 | $4.3 | 150,179 | 04-04-2024 |
$4.2 | $4.13 | $4.2 | $4.2641 | $4.12 | 92,084 | 04-03-2024 |
$4.17 | $4.2 | $4.17 | $4.25 | $4.035 | 50,668 | 04-02-2024 |
$4.26 | $4.23 | $4.26 | $4.29 | $4.2 | 63,365 | 04-01-2024 |
$4.24 | $4.17 | $4.24 | $4.31 | $4.17 | 93,670 | 03-29-2024 |
$4.24 | $4.17 | $4.24 | $4.31 | $4.17 | 93,670 | 03-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Harvard Bioscience Inc. Company Name:
HBIO Stock Symbol:
NASDAQ Market:
Harvard Bioscience Inc. Website:
Kiniksa Pharmaceuticals Ltd. (KNSA) is expected to report $-0.14 for Q1 2024 Agree Realty Corporation (ADC) is expected to report $1.01 for Q1 2024 1st Colonial Bancorp Inc (FCOB) is expected to report for Q1 2024 Equity Residential of Beneficial Interest (EQR) is expected to report $...
HOLLISTON, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced a labor force reduction to improve its operating cost structure and support its ongoing investments in growth. The Company expects to realize overall annual run rate savings of appro...
HOLLISTON, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at the upcoming Sidoti Small Cap Conference and KeyBanc Life Sciences & MedTech Conference, both t...